Provided by Tiger Fintech (Singapore) Pte. Ltd.

SILO PHARMA INC.

0.5811
-0.0589-9.20%
Post-market: 0.5600-0.0211-3.63%19:59 EDT
Volume:6.36M
Turnover:4.38M
Market Cap:4.19M
PE:-0.51
High:0.7900
Open:0.6326
Low:0.5800
Close:0.6400
Loading ...
May 16, 2025

Major Issues Report

Form 8-K - Current report
May 09, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 29, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 25, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mar 28, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 10, 2025

Major Issues Report

Form 8-K - Current report
Mar 07, 2025

Major Issues Report

Form 8-K - Current report
Jan 02, 2025

Major Issues Report

Form 8-K - Current report
Dec 20, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2024

Major Issues Report

Form 8-K - Current report
Sep 10, 2024

Major Issues Report

Form 8-K - Current report
Aug 30, 2024

Correspondence

Form CORRESP - Correspondence
Aug 21, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 27, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Jul 27, 2024

Correspondence

Form CORRESP - Correspondence
Jul 25, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jul 22, 2024

Major Issues Report

Form 8-K - Current report